The 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases returns to Boston this fall.
- Uncover recent studies evaluating critical inflammatory and auto-immune pathways
- Gain a deeper understanding of promising biologics targeting IL-13, IL-31, IL-33, versus IL-17 associated diseases
- Assess emerging efficacious targeted approaches in the plethora of conditions outside of these pathways.
- Obtain clarity on novel clinically validated endpoints within the regulatory landscape for critical dermatological conditions with high unmet needs such as Hidradenitis Suppurativa, Vitiligo, Rare Disease, and Alopecia Areata
View the event program here: https://ter.li/g3z67z
Register here: https://ter.li/vu3tx9
If you have any further questions regarding the summit, please contact us at info@hansonwade.com.